Buy or sell Caribou Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Caribou Biosciences Stock

Biotechnology company specializing in genome engineering



Notable Investors

Anterra Capital


Berkeley CA, US

Total Funding


About Caribou Biosciences Stock

Caribou Biosciences is a biotechnology company in genome engineering. We develop technology-based solutions for cellular engineering and analysis based on the CRISPR-Cas9 technology platform. Cas9, when paired with a guide RNA, cuts double-stranded DNA allowing for specific changes to DNA. These site-specific DNA modifications can be utilized to carry out sophisticated gene knock-outs or knock-ins.


Funding History

October 2014$2.9M
March 2015$11.5M
May 2016$30.0M
May 2016$30.1M



Jennifer A. Doudna


James Berger

Chief Scientific Officer

Andy May


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Caribou Biosciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: